Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.

Trial Identifier:	D3461R00087
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	November 2025
Study Completion Date:	November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Kazakhstan	Aktobe, Kazakhstan
Kazakhstan	Almaty, Kazakhstan
Kazakhstan	Pavlodar, Kazakhstan
Kazakhstan	Semey, Kazakhstan
Kazakhstan	Shymkent, Kazakhstan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company